MedTrace Logo

REGISTRY - an Observational Study of the European Huntington's Disease Network (EHDN)

NCT01590589 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2017-09-15

No results posted yet for this study

Summary

This is a multi-centre, multi-national, prospective, observational study of Huntington's disease (HD) with a control group of volunteers to:

* obtain natural history data on many HD mutation carriers and individuals who are part of an HD family
* relate phenotypical characteristics (genetic modifiers / wet and dry biomarkers)
* expedite identification and recruitment of participants for clinical trials
* develop and validate sensitive and reliable outcome measures for detecting onset and change over the natural course of premanifest and manifest HD which may also be potential outcome measures for use in future clinical trials and clinical care
* plan for future research studies

Conditions

Sponsors & Collaborators

  • European Huntington's Disease Network

    lead NETWORK

Principal Investigators

  • Bernhard Landwehrmeyer, Professor · University Hospital of Ulm / Dept. of Neurology

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-06-30
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • Austria
  • Belgium
  • Czechia
  • Denmark
  • Finland
  • France
  • Germany
  • Italy
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01590589 on ClinicalTrials.gov